<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "calcitonin inj VIAL>
<dose><value>4 - 8</value>
<value>1</value>
<value>100</value>
<value>50 - 100</value>
</dose><route><value>IM</value>
<value>INTRACUTANEOUSLY</value>
<value>SC</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>calcitonin inj VIAL</value>
</drugname><strength><value>200 unit/mL</value>
</strength><frequency><value>Q12H</value>
<value>Q8H</value>
<value>Q6H</value>
<value>ONCE</value>
<value>DAILY</value>
<value>THREE TIMES WEEKLY</value>
</frequency><instruction><value></value>
<value>Test Dose: Administer intracutaneously on the flexor surface of the forearm. Observe injection site for 15 minutes for wheal or significant erythema.</value>
</instruction><volume><value>2 mL</value>
</volume><units><value>unit/kg</value>
<value>unit</value>
</units><additionalnotes><value>Hypercalcemia</value>
<value>Hypercalcemia. MAXIMIM dose: 8 unit/kg every 6 hours.</value>
<value></value>
<value>Paget&amp;apos;s Disease. Initial dose.</value>
<value>Paget&amp;apos;s Disease. Maintenance dose.</value>
</additionalnotes><population><value>ADULT.</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=2003</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Parathyroid</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>